Helena Nordin Rudberg
Directeur Général chez Crane Ridge Pharma Consulting AB
Profil
Ms. Helena Nordin Rudberg is Chairman & Chief Executive Officer at Crane Ridge Pharma Consulting AB.
She is on the Board of Directors at Serendex Pharmaceuticals A/S, Reyholmia AB, and Swedish Investment Development Organization AB.
Ms. Rudberg was previously employed as Executive Vice President-Sales & Marketing by Biovitrum AB and Head-BU Hemophilia by Swedish Orphan Biovitrum AB.
Postes actifs de Helena Nordin Rudberg
| Sociétés | Poste | Début |
|---|---|---|
| Crane Ridge Pharma Consulting AB | Directeur Général | - |
| Reyholmia AB | Directeur/Membre du Conseil | - |
| Swedish Investment Development Organization AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Helena Nordin Rudberg
| Sociétés | Poste | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Sales & Marketing | - |
| SERENDEX PHARMACEUTICALS A/S | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
Serendex Pharmaceuticals A/S
 Serendex Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Serendex Pharmaceuticals A/S engages in the research and development of pharmaceuticals for respiratory conditions. It develops drugs to treat respiratory conditions such as Pulmonary Alveolar Proteinosis, Bronchiectasis, Cystic Fibrosis related lung infections and Diffuse Alveolar Hemorrhage. The company was founded by Lars Heslet on October 31, 2008 and is headquartered in Horsholm, Denmark. | Health Technology |
| Crane Ridge Pharma Consulting AB | |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
| Reyholmia AB | |
| Swedish Investment Development Organization AB |
